Display Settings:

Format

Send to:

Choose Destination
Curr Opin Investig Drugs. 2006 Oct;7(10):924-35.

Drug evaluation: tagatose in the treatment of type 2 diabetes and obesity.

Author information

  • Vanderbilt University School of Medicine, Department of Molecular Physiology and Biophysics, 702 Light Hall, Nashville, TN 37232, USA. genie.moore@vanderbilt.edu

Abstract

Spherix Inc (formerly Biospherics) is developing tagatose, an orally active lactose derivative for the potential treatment of obesity and type 2 diabetes. The compound is also under investigation for the potential treatment of anemia, hemophilia and medical problems related to infertility, birth weight and excessive maternal food intake. Phase I and II clinical trials have been completed.

PMID:
17086938
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk